0
0
Nearly 180,000 allopathic doctors across Maharashtra held a 24-hour strike on September 18, 2025, opposing the state government’s move to allow homeopathic practitioners with a Certificate Course in Modern Pharmacology (CCMP) to register with the Maharashtra Medical Council (MMC) and prescribe allopathic medicines in select cases. The widespread protest involved government, Brihanmumbai Municipal Corporation (BMC), and private hospital doctors, reflecting deep-rooted concerns over patient safety and the quality of healthcare services in the state.
Background and Key Developments
The controversy stems from a government circular issued on September 5, 2025, which revived a policy allowing homeopaths who completed a year-long CCMP course under Maharashtra University of Health Sciences (MUHS), Nashik, to register with the MMC. The CCMP program provides homeopathic practitioners training in modern pharmacology with an aim to enable them to prescribe allopathic medicines, particularly in public healthcare settings. The initial notification and registration process had been withdrawn earlier after opposition from the Indian Medical Association (IMA) Maharashtra chapter, which led to a temporary suspension following threats of a strike in July 2025.
The strike reflects strong opposition from allopathic doctors, including resident doctors’ organizations, the Federation of All India Medical Association, and government medical associations. Dr. Santosh Kadam, President of IMA Maharashtra, emphasized that the registration of CCMP-qualified homeopaths “poses a serious threat to the safety of patients and quality of healthcare services.” The strike was peaceful, with emergency and critical services continuing uninterrupted.
Expert Perspectives and Medical Community Response
Leading medical professionals not involved with the policy have voiced caution. Dr. Meera Joshi, a senior consultant physician unaffiliated with the controversy, noted, “While cross-training in pharmacology can be beneficial, licensure to prescribe allopathic medicines must align closely with comprehensive medical training to safeguard patient care standards.” She cautioned that the scope of a one-year certificate course is significantly narrower than the extensive training required in allopathic medical education, calling for rigorous evaluation and clear regulatory oversight before allowing such practice.
The IMA argues that only fully qualified MBBS doctors should be licensed to prescribe modern medicines, highlighting concerns that insufficient training in pathology, diagnosis, and treatment among CCMP practitioners could compromise patient safety and lead to medical errors.
Legal and Regulatory Context
The dispute has legal dimensions as well. In 2014, the Bombay High Court stayed a similar government notification after IMA challenged the amendments permitting homeopaths with CCMP to practice allopathy. The issue remains pending in court, lending complexity to the ongoing debate.
The Maharashtra Medical Education and Drugs Department had constituted a seven-member special committee to evaluate the implications of CCMP registration and practice rights. Despite this, the revocation and reissuance of government resolutions fuel uncertainty among allopathic practitioners and patients alike.
Public Health Implications
From a public health perspective, integrating multiple healthcare systems can enhance access, especially in underserved areas where allopathic doctors are scarce. The state’s rationale behind the CCMP initiative emphasizes improving healthcare delivery by enabling trained homeopaths to fill gaps in primary care services.
However, experts stress that patient safety and healthcare quality cannot be compromised. The limited training scope of the CCMP program—compared to comprehensive allopathic medical training—raises valid concerns about diagnostic accuracy, medication side effects, drug interactions, and emergency management. Such gaps can lead to adverse outcomes, which is why robust research and clear guidelines are critical before expanding prescribing rights to non-allopathic practitioners.
Balanced Reporting and Considerations
While the government seeks to improve healthcare access through innovative approaches like the CCMP certification, the medical fraternity’s concerns reflect the potential risks of medically underqualified professionals prescribing allopathic drugs. It underscores the need for transparent evaluation, rigorous credentialing, and ongoing monitoring to ensure patient safety.
Further studies and regulatory reviews might be necessary to ascertain the clinical outcomes of such integrative practices. Until then, the voices from both sides emphasize the importance of safeguarding public trust and healthcare quality.
What This Means for Readers
For general consumers and patients, this strike and policy controversy illustrate ongoing challenges in healthcare regulation—balancing access with safety. Understanding the credentials and scope of practice of healthcare providers is crucial when seeking treatment. Patients should feel empowered to ask about the qualifications of anyone prescribing medicines and to consult licensed allopathic doctors for conditions requiring detailed diagnosis and management.
Medical Disclaimer
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
-
Medical Dialogues. “Around 1.8 lakh doctors strike in Maharashtra against Homeopath-CCMP registration.” September 18, 2025.https://medicaldialogues.in/news/health/doctors/around-18-lakh-doctors-strike-in-maharashtra-against-homeopath-ccmp-registration-155437
